Abstract
Whereas minor side effects of sulfasalazine are common, serious adverse reactions to this drug generally are considered rare. However, this report discusses three major complications of sulfasalazine that occurred within the past three years, one resulting in the death of a patient. As more patients with inflammatory bowel disease are being managed by physicians of various disciplines, it is important to become familiar with the potentially dangerous side effects of all medications prescribed. For this reason, a brief review of the pharmacology, clinical use, and toxicity of sulfasalazine is presented.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Das KM, Eastwood MA, McManus JP, Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with the drug metabolism and acetylator phenotype. N Engl J Med 1973;289:491–5.
Peppercorn MA. Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 1984; 101:377–86.
Das KM, Sternlieb I. Salicylazosulfapyridine in inflammatory bowel disease. Dig Dis Sci 1975;20:971–6.
Baron JH, Connell AM, Lennard-Jones JE, Jones FA. Sulfasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet 1962;1:1094–6.
Misiewicz JJ, Lennard-Jones JE, Connell AM, Baron JH, Jones FA. Controlled trial of sulfasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185–8.
Summers RW, Switz DM, Sessions JT Jr et al. National cooperative Crohn's disease study: results of drug treatment. Gastroenterology 1979;77:847–69.
Author information
Authors and Affiliations
About this article
Cite this article
Pearl, R.K., Nelson, R.L., Prasad, M.L. et al. Serious complications of sulfasalazine. Dis Colon Rectum 29, 201–202 (1986). https://doi.org/10.1007/BF02555026
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555026